Agilent Technologies, Inc. (NYSE:A) – Leerink Swann cut their Q1 2019 earnings estimates for shares of Agilent Technologies in a report released on Tuesday. Leerink Swann analyst P. Souda now expects that the medical research company will earn $0.66 per share for the quarter, down from their prior estimate of $0.70. Leerink Swann also issued estimates for Agilent Technologies’ Q2 2019 earnings at $0.70 EPS, Q3 2019 earnings at $0.71 EPS and Q4 2019 earnings at $0.77 EPS.

Other equities analysts have also issued research reports about the stock. Deutsche Bank AG set a $68.00 price target on shares of Agilent Technologies and gave the stock a “buy” rating in a report on Wednesday, August 16th. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Cowen and Company reissued a “hold” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Wednesday. Bank of America Corporation increased their price target on shares of Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 16th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Wednesday, August 16th. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Agilent Technologies has an average rating of “Buy” and an average target price of $68.20.

ILLEGAL ACTIVITY WARNING: This report was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/agilent-technologies-inc-forecasted-to-earn-q1-2019-earnings-of-0-66-per-share-a/1722530.html.

Agilent Technologies (NYSE A) traded down $1.22 during trading on Thursday, reaching $68.69. 3,041,700 shares of the company were exchanged, compared to its average volume of 1,857,755. The company has a market cap of $21,720.00, a price-to-earnings ratio of 29.50, a PEG ratio of 2.76 and a beta of 1.28. Agilent Technologies has a twelve month low of $42.92 and a twelve month high of $70.81. The company has a quick ratio of 2.76, a current ratio of 3.30 and a debt-to-equity ratio of 0.37.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a net margin of 14.89% and a return on equity of 15.05%. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.59 EPS.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. The ex-dividend date is Friday, December 29th. This represents a $0.60 annualized dividend and a yield of 0.87%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is presently 25.24%.

In other Agilent Technologies news, Director Boon Hwee Koh sold 4,500 shares of the stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Michael R. Mcmullen sold 16,492 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $65.33, for a total transaction of $1,077,422.36. Following the sale, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. Insiders have sold a total of 107,709 shares of company stock valued at $7,195,576 in the last three months.

Hedge funds and other institutional investors have recently modified their holdings of the business. Dupont Capital Management Corp bought a new position in shares of Agilent Technologies in the 3rd quarter worth about $101,000. Balentine LLC increased its stake in shares of Agilent Technologies by 2.9% in the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after acquiring an additional 50 shares in the last quarter. Sun Life Financial INC increased its stake in shares of Agilent Technologies by 26,144.4% in the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after acquiring an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC increased its stake in shares of Agilent Technologies by 92.3% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Parallel Advisors LLC increased its stake in shares of Agilent Technologies by 5.3% in the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after acquiring an additional 131 shares in the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.